Dilated cardiomyopathy risk factors: Difference between revisions
Jump to navigation
Jump to search
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dilated cardiomyopathy}} | |||
{{CMG}}; {{AE}}{{AIA}} | |||
== Overview == | == Overview == | ||
Common risk factors in the development of dilated cardiomyopathy | Common [[Risk factor|risk factors]] in the development of [[dilated cardiomyopathy]] include [[Genetics|genetic]] inheritance, [[nutritional deficiencies]], [[substance abuse]], [[Occupational exposure limit|occupational exposure]] to [[Toxin|toxins]], and [[Virus|viral infections]]. | ||
== Risk Factors == | == Risk Factors == | ||
Common risk factors in the development of dilated cardiomyopathy include genetic inheritance, nutritional deficiencies, | Common [[Risk factor|risk factors]] in the development of [[dilated cardiomyopathy]] include [[genetic inheritance]], [[nutritional deficiencies]], [[substance abuse]], [[Occupational exposure limit|occupational exposure]] to [[Toxin|toxins]], and [[Virus|viral infections]].<ref name="pmid10760308">{{cite journal| author=Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al.| title=Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. | journal=N Engl J Med | year= 2000 | volume= 342 | issue= 15 | pages= 1077-84 | pmid=10760308 | doi=10.1056/NEJM200004133421502 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10760308 }}</ref><ref name="pmid28912180">{{cite journal| author=McNally EM, Mestroni L| title=Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. | journal=Circ Res | year= 2017 | volume= 121 | issue= 7 | pages= 731-748 | pmid=28912180 | doi=10.1161/CIRCRESAHA.116.309396 | pmc=5626020 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28912180 }}</ref><ref name="pmid9770563">{{cite journal| author=Lipshultz SE| title=Dilated cardiomyopathy in HIV-infected patients. | journal=N Engl J Med | year= 1998 | volume= 339 | issue= 16 | pages= 1153-5 | pmid=9770563 | doi=10.1056/NEJM199810153391609 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9770563 }}</ref><ref name="pmid30278496">{{cite journal| author=Li X, Nie Y, Lian H, Hu S| title=Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy. | journal=Medicine (Baltimore) | year= 2018 | volume= 97 | issue= 39 | pages= e12259 | pmid=30278496 | doi=10.1097/MD.0000000000012259 | pmc=6181549 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30278496 }}</ref> | ||
=== Common Risk Factors === | === Common Risk Factors === | ||
* Common risk factors in the development of dilated cardiomyopathy include: | * Common [[Risk factor|risk factors]] in the development of [[dilated cardiomyopathy]] include: | ||
** [ | **[[Genetic inheritance]] | ||
** [ | **[[Substance abuse|Substance]] ([[cocaine]]/[[amphetamine]]) and [[Alcohol, Drug Abuse, and Mental Health Services Block Grant|alcohol]] abuse | ||
** [ | **Drugs ([[Doxorubicin hydrochloride|Doxorubicin]], [[Cyclophosphamide]], and [[AIDS antiretroviral drugs|antiretroviral drugs]]) | ||
**[[Virus|Viral infections]] as [[Adenoviridae|adenovirus]] and [[Coxsackie virus|coxsackie]] virus. | |||
**[[Occupational exposure limit|Occupational exposure]] to industrial [[Toxin|toxins]] as [[Toxins|cobalt, lead or beryllium]] | |||
**[[Nutritional deficiencies]] as [[thiamine]] and [[selenium]]. | |||
=== Less Common Risk Factors === | === Less Common Risk Factors === | ||
* Less common risk factors in the development of dilated cardiomyopathy include: | * Less common [[Risk factor|risk factors]] in the development of [[dilated cardiomyopathy]] include: | ||
** [ | **[[Radiation]] | ||
** [ | **[[Heat stroke]] | ||
** [ | **[[Carbon monoxide poisoning]] | ||
__NOTOC__ | __NOTOC__ | ||
{{Dilated cardiomyopathy}} | {{Dilated cardiomyopathy}} | ||
==References== | ==References== | ||
Latest revision as of 16:38, 30 December 2019
|
Dilated cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dilated cardiomyopathy risk factors On the Web |
|
American Roentgen Ray Society Images of Dilated cardiomyopathy risk factors |
|
Risk calculators and risk factors for Dilated cardiomyopathy risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
Common risk factors in the development of dilated cardiomyopathy include genetic inheritance, nutritional deficiencies, substance abuse, occupational exposure to toxins, and viral infections.
Risk Factors
Common risk factors in the development of dilated cardiomyopathy include genetic inheritance, nutritional deficiencies, substance abuse, occupational exposure to toxins, and viral infections.[1][2][3][4]
Common Risk Factors
- Common risk factors in the development of dilated cardiomyopathy include:
- Genetic inheritance
- Substance (cocaine/amphetamine) and alcohol abuse
- Drugs (Doxorubicin, Cyclophosphamide, and antiretroviral drugs)
- Viral infections as adenovirus and coxsackie virus.
- Occupational exposure to industrial toxins as cobalt, lead or beryllium
- Nutritional deficiencies as thiamine and selenium.
Less Common Risk Factors
- Less common risk factors in the development of dilated cardiomyopathy include:
|
Dilated cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dilated cardiomyopathy risk factors On the Web |
|
American Roentgen Ray Society Images of Dilated cardiomyopathy risk factors |
|
Risk calculators and risk factors for Dilated cardiomyopathy risk factors |
References
- ↑ Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL; et al. (2000). "Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy". N Engl J Med. 342 (15): 1077–84. doi:10.1056/NEJM200004133421502. PMID 10760308.
- ↑ McNally EM, Mestroni L (2017). "Dilated Cardiomyopathy: Genetic Determinants and Mechanisms". Circ Res. 121 (7): 731–748. doi:10.1161/CIRCRESAHA.116.309396. PMC 5626020. PMID 28912180.
- ↑ Lipshultz SE (1998). "Dilated cardiomyopathy in HIV-infected patients". N Engl J Med. 339 (16): 1153–5. doi:10.1056/NEJM199810153391609. PMID 9770563.
- ↑ Li X, Nie Y, Lian H, Hu S (2018). "Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy". Medicine (Baltimore). 97 (39): e12259. doi:10.1097/MD.0000000000012259. PMC 6181549. PMID 30278496.